HomepageMedicineGSK Completes Acquisition of Aiolos Bio Medicine GSK Completes Acquisition of Aiolos Bio admin Posted on February 16, 2024 This acquisition will add asthma treatment A1O-001 to GSK’s portfolio. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostIFSCA Chairman promises clarity on family office structures for resident HNIs in 2-3 months Next PostA.I. Art That’s More Than a Gimmick? Meet AARON You Might Also Like Medicine US Pharma and Biotech Summit 2024: Bringing the Skillset of Generation Alpha to the Pharma Industry admin May 23, 2024 Medicine Novartis Terminates Licensing Rights With Allarity for Cancer Drug Due to Missed Payments admin February 5, 2024 Medicine Zepbound Expected to Surpass Wegovy in Weight Loss Market, New Report States admin January 6, 2025 Medicine Pharma Pulse 8/2/24: Poor Data is a Population Health Risk, Meta’s Earnings Calm AI Jitters & more admin August 4, 2024
Medicine US Pharma and Biotech Summit 2024: Bringing the Skillset of Generation Alpha to the Pharma Industry admin May 23, 2024
Medicine Novartis Terminates Licensing Rights With Allarity for Cancer Drug Due to Missed Payments admin February 5, 2024
Medicine Zepbound Expected to Surpass Wegovy in Weight Loss Market, New Report States admin January 6, 2025
Medicine Pharma Pulse 8/2/24: Poor Data is a Population Health Risk, Meta’s Earnings Calm AI Jitters & more admin August 4, 2024